AstraZeneca's sipavibart shows promising results in Phase III COVID-19 prevention trial for immunocompromised patients, reducing symptomatic cases significantly. A potential game-changer in protecting vulnerable populations.
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
UPMC enrolls liver transplant patients sidelined by pause of Hershey Med's program pennlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pennlive.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca's sipavibart shown to prevent COVID-19 in immunocompromised patients pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.
GLP-1 receptor agonists confer better outcomes after AF ablation in patients with diabetes healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.